LINC00116-encoded microprotein mitoregulin regulates fatty acid metabolism at the mitochondrial outer membrane
Shan Zhang,
Yabo Guo,
Gio Fidelito,
David R.L. Robinson,
Chao Liang,
Radiance Lim,
Zoë Bichler,
Ruiyang Guo,
Gaoqi Wu,
He Xu,
Quan D. Zhou,
Brijesh K. Singh,
Paul Yen,
Dennis Kappei,
David A. Stroud,
Lena Ho
Affiliations
Shan Zhang
Department of Biochemistry, Department of Cardiology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; Corresponding author
Yabo Guo
Department of Biochemistry, Department of Cardiology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China
Gio Fidelito
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore
David R.L. Robinson
Department of Biochemistry and Pharmacology, The Bio21 Molecular Science & Biotechnology Institute, University of Melbourne, Melbourne, VIC 3010, Australia
Chao Liang
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore
Radiance Lim
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore
Zoë Bichler
Behavioral Neuroscience Laboratory, National Neuroscience Institute, Singapore 308433, Singapore
Ruiyang Guo
Department of Biochemistry, Department of Cardiology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China
Gaoqi Wu
Institute of Immunology, Department of Surgical Oncology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China
He Xu
Institute of Immunology, Department of Surgical Oncology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China
Quan D. Zhou
Institute of Immunology, Department of Surgical Oncology of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China
Brijesh K. Singh
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore
Paul Yen
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore
Dennis Kappei
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore
David A. Stroud
Department of Biochemistry and Pharmacology, The Bio21 Molecular Science & Biotechnology Institute, University of Melbourne, Melbourne, VIC 3010, Australia; Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, VIC 3010, Australia; Victorian Clinical Genetics Services, Murdoch Children’s Research Institute, Melbourne, VIC 3010, Australia
Lena Ho
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; Corresponding author
Summary: LINC00116 encodes a microprotein first identified as Mitoregulin (MTLN), where it was reported to localize to the inner membrane of mitochondria to regulate fatty acid oxidation and oxidative phosphorylation. These initial discoveries were followed by reports with differing findings about its molecular functions and submitochondrial localization. To clarify the apparent discrepancies, we constructed multiple orthogonal methods of determining the localization of MTLN, including split GFP-based reporters that enable efficient and reliable topology analyses for microproteins. These methods unequivocally demonstrate MTLN primarily localizes to the outer membrane of mitochondria, where it interacts with enzymes of fatty acid metabolism including CPT1B and CYB5B. Loss of MTLN causes the accumulation of very long-chain fatty acids (VLCFAs), especially docosahexaenoic acid (DHA). Intriguingly, loss of MTLN protects mice against western diet/fructose-induced insulin-resistance, suggests a protective effect of VLCFAs in this context. MTLN thus serves as an attractive target to control the catabolism of VLCFAs.